Suppr超能文献

毛蕊花糖苷抑制高脂饮食诱导的动脉粥样硬化大鼠模型中动脉粥样硬化的进展。

Verbascoside inhibits the progression of atherosclerosis in high fat diet induced atherosclerosis rat model.

作者信息

Fan Y, Zhang K

机构信息

Department of Cardiovascular Medicine, Inner Mongolia People's Hospital, Saihan District, Hohhot, Inner Mongolia Autonomous Region, Peoples Republic of China.

Department of Emergency, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, Peoples Republic of China.

出版信息

J Physiol Pharmacol. 2021 Jun;72(3). doi: 10.26402/jpp.2021.3.03. Epub 2021 Nov 19.

Abstract

Atherosclerosis is thickening of arterial wall, which causes several complications. This study evaluated the protective effect of verbascoside against atherosclerosis and the potential molecular mechanism involved. Atherosclerosis was induced by administering a high-fat diet to rats for 3 months and vitamin D for 4 days. Verbascoside (2 mg/kg p.o.) was administered for 6 weeks after the end of high-fat diet administration. The serum levels of inflammatory mediators and the lipid profile were determined, and atherosclerotic lesions were observed via Sudan IV staining. Moreover, immunohistochemical analysis, Western blot assay and qRT-PCR were performed to determine the effect of verbascoside on the AMPK/mTOR pathway in atherosclerosis. The results reveal that verbascoside ameliorated the altered serum levels of inflammatory mediators and the lipid profile as well as the organ coefficients in the atherosclerotic rats. A significant decrease in atherosclerotic lesions was detected in the verbascoside-treated group than the atherosclerosis group. AMPK and mTOR mRNA expression decreased in aortic tissues of the verbascoside-treated group compared to the atherosclerosis group. These data suggest that verbascoside ameliorates atherosclerosis by decreasing hyperlipidaemia in atherosclerosis induced by a high-fat diet.

摘要

动脉粥样硬化是动脉壁增厚,会引发多种并发症。本研究评估了毛蕊花糖苷对动脉粥样硬化的保护作用及其潜在的分子机制。通过给大鼠喂食高脂饮食3个月并给予维生素D 4天来诱导动脉粥样硬化。在高脂饮食给药结束后,给予毛蕊花糖苷(2毫克/千克,口服)6周。测定炎症介质的血清水平和血脂谱,并通过苏丹IV染色观察动脉粥样硬化病变。此外,进行免疫组织化学分析、蛋白质印迹分析和定量逆转录聚合酶链反应,以确定毛蕊花糖苷对动脉粥样硬化中AMPK/mTOR通路的影响。结果显示,毛蕊花糖苷改善了动脉粥样硬化大鼠血清中炎症介质水平和血脂谱的改变以及器官系数。与动脉粥样硬化组相比,毛蕊花糖苷治疗组的动脉粥样硬化病变显著减少。与动脉粥样硬化组相比,毛蕊花糖苷治疗组主动脉组织中AMPK和mTOR mRNA表达降低。这些数据表明,毛蕊花糖苷通过降低高脂饮食诱导的动脉粥样硬化中的高脂血症来改善动脉粥样硬化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验